Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3482]
News [8238]
Articles [66]
Editorials [9]
Conferences [224]
elearning [49]
IAEA launches worldwide rays of hope partnership with 11 global cancer societies in cancer care
IAEA launches worldwide rays of hope partnership with 11 global cancer societies in cancer care
SABCS 2022: First-line ribociclib plus endocrine therapy may be more effective than combination chemotherapy in patients with aggressive breast cancer
SABCS 2022: First-line ribociclib plus endocrine therapy may be more effective than combination chemotherapy in...
SABCS 2022: HER2-low and HER2-zero triple-negative breast cancer show distinct biological differences
SABCS 2022: HER2-low and HER2-zero triple-negative breast cancer show distinct biological differences
Advancing breast cancer clinical trial design - Prof Hendrik-Tobias Arkenau
Advancing breast cancer clinical trial design - Prof Hendrik-Tobias Arkenau
Research on rare genetic disease sheds light on a common head and neck cancer
Research on rare genetic disease sheds light on a common head and neck cancer
Newfound cancer cell biology suggests which patients will respond to immunotherapy
Newfound cancer cell biology suggests which patients will respond to immunotherapy
Discovery could lead to new drugs to block protein that fuels bowel cancer
Discovery could lead to new drugs to block protein that fuels bowel cancer
European Commission approves zanubrutinib for the treatment of adults with marginal zone lymphoma
European Commission approves zanubrutinib for the treatment of adults with marginal zone lymphoma
Darolutamide + ADT in combination with docetaxel licenced by MHRA and made immediately available through NHS England early access deal for the treatment of patients with mHSPC
Darolutamide + ADT in combination with docetaxel licenced by MHRA and made immediately available through NHS...
Novel nanoparticles deliver innovative cancer chemoimmunotherapy
Novel nanoparticles deliver innovative cancer chemoimmunotherapy

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation